results found
This chart collection accompanies a related brief that explores recent trends in spending on prescription drugs among people with employer coverage, with a particular focus on people with high drug spending and high out-of-pocket drug spending. …
In a given year, a small portion of the population is responsible for a very large percentage of total health spending. We tend to focus on averages when discussing health spending, but individuals’ health status – and thus their need …
Over the past half-century, the U.S. has seen sizable improvements in both mortality and disease burden due to cardiovascular disease, along with recent signs of improvement in the quality of care provided to heart disease patients. Cardiovascular disease — which …
An updated version of this brief is available here.
Rising cost-sharing for people with health insurance has drawn a good deal of public attention in recent years. For example, the average deductible for people with employer-provided health coverage rose from …
The recent slowdown in health spending growth continued through 2013, according to a new report released by the Centers for Medicare and Medicaid Services (CMS). Health spending per capita grew at 2.9% in 2013, a continuation of the historically low …
This brief is the result of a collaboration between the Kaiser Family Foundation and the United States Bureau of Economic Analysis. Cynthia Cox is with the Kaiser Family Foundation; Abe Dunn, Lindsey Rittmueller, and Bryn Whitmire are with the Bureau …
This collection of charts and a related brief explore recent trends in health outcomes and treatment costs for cancer in both the U.S. and comparable countries (those with similarly large GDP and GDP per capita). Compared to similar countries, the …
Compared to similar countries, the United States has higher rates of mortality for most of the leading causes of death, and generally performs worse on a variety of quality indicators. Cancer, however, is one area where the U.S. stands out …
The cost of prescription drugs has received a good deal of attention recently, driven in part by a spike is spending in 2014 and 2015. After several years of fairly low growth, per capita prescription drugs costs are estimated to …
The Bureau of Economic Analysis (BEA) recently updated their disease-based health spending estimates with new data that allows users to examine national health spending trends by disease category from 2000 – 2012. The BEA satellite account differs from the official …